Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/17/2009 | US20090311275 Carrier for targeting nerve cells |
12/17/2009 | US20090311274 Polynucleotide coding tumor protein for use as preventive, diagnostic and prognostic tool in treatment of cell proliferative disorders |
12/17/2009 | US20090311268 Cd40-binding activating antibodies |
12/17/2009 | US20090311263 Human vascular ibp-like growth factor |
12/17/2009 | US20090311261 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
12/17/2009 | US20090311260 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
12/17/2009 | US20090311259 maytansinoid drug moieties covalently linked by a linker to an antibody which binds to an ErbB receptor, or which binds to one or more tumor-associated antigens or cell-surface receptors; cancer |
12/17/2009 | US20090311257 Human antibodies specific for gastrin materials and methods |
12/17/2009 | US20090311256 12 Human Secreted Proteins |
12/17/2009 | US20090311253 Dual Variable Domain Immunoglobulins and Uses Thereof |
12/17/2009 | US20090311244 Screening Method |
12/17/2009 | US20090311233 Materials and methods directed to asparagine synthetase and asparaginase therapies |
12/17/2009 | US20090311225 Compositions of and Methods of Using Stabilized PSMA Dimers |
12/17/2009 | US20090311224 Therapeutic agent comprising lipocalin 2 against cancer metastasis, and methods of early diagnosis and inhibition of cancer metastasis using lipocalin 2 |
12/17/2009 | US20090311216 Recombinant interferon-beta with enhanced biological activity |
12/17/2009 | US20090311194 Methods and compositions for the production and use of magnetosomes |
12/17/2009 | US20090308736 Apparatus and method for specific release of captured extension products |
12/17/2009 | US20090308041 Altering the fatty acid composition of rice |
12/17/2009 | CA2728232A1 Cell lysis reagent for isolation of rna |
12/17/2009 | CA2727811A1 Conjugates for the administration of biologically active compounds |
12/17/2009 | CA2727795A1 Genetic component of complications in type 2 diabetes |
12/17/2009 | CA2727790A1 Reagents and methods for detecting a polymorphic protein |
12/17/2009 | CA2727681A1 Programming and reprogramming of cells |
12/17/2009 | CA2727657A1 Anti-angiogenic compositions and therapeutic applications thereof |
12/17/2009 | CA2727637A1 Bollworm insect resistance management in transgenic plants |
12/17/2009 | CA2727633A1 Use of mir-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy |
12/17/2009 | CA2727628A1 Improved protein expression system |
12/17/2009 | CA2727614A1 Novel bacillus thuringiensis gene with lepidopteran activity |
12/17/2009 | CA2727613A1 Novel bacillus thuringiensis gene with lepidopteran activity |
12/17/2009 | CA2727598A1 Compositions and methods of use of mitogen-activated protein kinase kinase kinase |
12/17/2009 | CA2727564A1 Methods and means of increasing the water use efficiency of plants |
12/17/2009 | CA2727560A1 Selection method ii |
12/17/2009 | CA2727485A1 Iqgap3 epitope peptides and vaccines containing the same |
12/17/2009 | CA2727430A1 Constructs for expressing herbicide tolerance genes, related plants, and related trait combinations |
12/17/2009 | CA2727341A1 Novel bmp-12-related proteins and methods of their manufacture |
12/17/2009 | CA2727285A1 Inhibition of hrp-3 using modified oligonucleotides |
12/17/2009 | CA2727141A1 Compositions and methods for modulating nicotinic/nmda receptor function |
12/17/2009 | CA2727086A1 Compositions and methods for modulating d1-d2 dopamine receptor interaction and function |
12/17/2009 | CA2727082A1 Suppression of neuroendocrine diseases |
12/17/2009 | CA2727030A1 Methods in increasing grain value by improving grain yield and quality |
12/17/2009 | CA2727010A1 Methods for improving viability and productivity in cell culture |
12/17/2009 | CA2727006A1 Methods for obtaining high viable cell density in mammalian cell culture |
12/17/2009 | CA2726850A1 Method of synthesizing polynucleotide variants |
12/17/2009 | CA2726825A1 Compositions and methods for producing fermentable carbohydrates in plants |
12/17/2009 | CA2726768A1 Methods and compositions for generation of bax- and bak-deficient cell lines |
12/17/2009 | CA2726092A1 Suppression of cancers |
12/17/2009 | CA2720365A1 Bcr-complex-specific antibodies and methods of using same |
12/17/2009 | CA2719679A1 Microorganisms for the production of adipic acid and other compounds |
12/17/2009 | CA2718337A1 Direct selection of structurally defined aptamers |
12/16/2009 | EP2133432A1 Use of snail1 activity inhibiting compounds in the preparation of pharmaceutical compositions intended for the treatment of chondrodystrophies, method for identifying inhibiting compounds, pharmaceutical compositions, chondrodystrophy diagnosis method and applications thereof |
12/16/2009 | EP2133430A2 Design and therapeutic use of adpase enhanced apyrases |
12/16/2009 | EP2133428A1 New baculovirus vectors for improved protein production |
12/16/2009 | EP2133427A1 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
12/16/2009 | EP2133426A2 Compositions and methods for the modification of gene transcription |
12/16/2009 | EP2133425A1 Method and compound for antiviral (HIV) therapy |
12/16/2009 | EP2133424A1 Peptide transporting to chromoplasts in petals and method of constructing plant having yellowish petals by using the same |
12/16/2009 | EP2133423A1 Germ cell marker using fish vasa gene |
12/16/2009 | EP2133422A1 Biological substance analysis chip, biological substance analysis kit and method of biological substance analysis using them |
12/16/2009 | EP2133421A1 Transgenic birds and protein production in the egg white |
12/16/2009 | EP2133420A1 Method for manufacturing L-amino acids using improved strains of the enterobacteriaceae family |
12/16/2009 | EP2133417A1 Microorganism capable of producing l-glutamic acid-type amino acid, and method for production of amino acid |
12/16/2009 | EP2133416A1 Recombinant microorganism |
12/16/2009 | EP2133362A1 Antagonists and agonists of LDCAM and methods of use |
12/16/2009 | EP2133360A2 Environmental stress tolerance genes |
12/16/2009 | EP2133359A2 Recombinant haemophilus influenzae adhesin proteins |
12/16/2009 | EP2133100A1 MTB32A Antigen of mycobacterium tuberculosis with inactivated active site and fusion proteins thereof |
12/16/2009 | EP2133098A1 G-CSF conjugates |
12/16/2009 | EP2132984A2 Interferon-like protein ZCYTO21 |
12/16/2009 | EP2132327A2 Gene expression signature for classification of cancers |
12/16/2009 | EP2132321A1 Pig model for psoriasis |
12/16/2009 | EP2132320A1 Insect resistant cotton plants and methods for identifying same |
12/16/2009 | EP2132319A1 Method for producing an antifungal peptide in a filamentous fungal host cell |
12/16/2009 | EP2132318A2 Compositions and methods for reducing h2s levels in fermented beverages |
12/16/2009 | EP2132317A1 Delta-8 desaturases and their use in making polyunsaturated fatty acids |
12/16/2009 | EP2132315A1 Reoviruses having modified sequences |
12/16/2009 | EP2132314A2 Variant activin receptor polypeptides and uses thereof |
12/16/2009 | EP2132313A1 Inhibitors of mrp4 for the treatment of vascular disorders |
12/16/2009 | EP2132312A2 Constructs and libraries comprising antibody surrogate light chain sequences |
12/16/2009 | EP2132311A1 Reagents for nucleic acid purification |
12/16/2009 | EP2132310A2 Reduction of polyalanine-induced protein aggregates and toxicity by ubiquilin |
12/16/2009 | EP2132309A2 Compositions and methods for treating glycogen storage diseases |
12/16/2009 | EP2132305A2 Genes encoding z,z-farnesyl diphosphate synthase and a sesquiterpene synthase with multiple products and uses thereof |
12/16/2009 | EP2132228A1 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof |
12/16/2009 | EP2132224A1 Cyclic receptor-associated protein (rap) peptides |
12/16/2009 | EP2132218A1 Transferases, epimerases, polynucleotides encoding these and uses thereof |
12/16/2009 | EP2131863A1 A method of treating malignant mesothelioma |
12/16/2009 | EP2131851A1 Nell-1 enhanced bone mineralization |
12/16/2009 | EP2131848A2 Compositions and methods for potentiated activity of biologicaly active molecules |
12/16/2009 | EP2131662A1 Process of producing tomato paste |
12/16/2009 | EP1794306B1 Stress resistant plants |
12/16/2009 | EP1716181B1 Cdr-repaired antibodies |
12/16/2009 | EP1604020B1 Method to confer cell culture replication activity to different hepatitis c virus isolates |
12/16/2009 | EP1597381B1 Production of modified glycoproteins having multiple antennary structures |
12/16/2009 | EP1576159B9 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
12/16/2009 | EP1521832B1 Anti-fragilis antibody and uses thereof |
12/16/2009 | EP1407023B1 Group b streptococcus antigens and corresponding dna fragments |
12/16/2009 | EP1287147B1 Immunotoxin fusion proteins and means for expression thereof |
12/16/2009 | EP1135469B1 An improved method for the production and purification of adenoviral vectors |
12/16/2009 | EP1114189B1 Recombinant newcastle disease virus rna expression systems and vaccines |
12/16/2009 | EP1012299B1 Lipid kinase |